𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic research in untreated acute promyelocytic leukemia

✍ Scribed by Estey, E

Book ID
110056289
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
67 KB
Volume
19
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Arsenic trioxide and low-dose cytarabine
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia
✍ Gail J. Roboz; Ellen K. Ritchie; Tania Curcio; Juliette Provenzano; Rebecca Carl πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 135 KB

## Abstract ## BACKGROUND. Acute myeloid leukemia (AML) carries a dismal prognosis in older patients. In this study, the authors evaluated the safety and efficacy of arsenic trioxide combined with low‐dose cytarabine in untreated patients aged β‰₯60 years with AML. ## METHODS. In a phase 1/2 desig

Acute promyelocytic leukemia in children
Acute promyelocytic leukemia in children
✍ Chan, Ka Wah ;Steinherz, Peter G. ;Miller, Denis R. πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 737 KB

## Abstract Sixteen children (ages 2–17) with acute promyelocytic leukemia (APL) were studied retrospectively. Diagnosis was based on clinical features and morphological criteria of the FAB classification. Bleeding diathesis was the predominant presenting symptom (>85%), associated with laboratory